September is designated as “Gynaecological Cancer Awareness Month”, with various global activities that highlight and increase awareness of gynaecological cancers for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of gynaecological cancers, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy”
by Giuseppe Schepisi, Chiara Casadei, Ilaria Toma, Giulia Poti, Maria Laura Iaia, Alberto Farolfi, Vincenza Conteduca, Cristian Lolli, Giorgia Ravaglia, Nicole Brighi et al.
Cancers 2021, 13(4), 840; https://doi.org/10.3390/cancers13040840
Available online: https://www.mdpi.com/2072-6694/13/4/840

“Fertility-Sparing Surgery in Gynecologic Cancer: A Systematic Review”
by Teska Schuurman, Sanne Zilver, Sanne Samuels, Winnie Schats, Frédéric Amant, Nienke van Trommel and Christianne Lok
Cancers 2021, 13(5), 1008; https://doi.org/10.3390/cancers13051008
Available online: https://www.mdpi.com/2072-6694/13/5/1008

“Small Non-Coding-RNA in Gynecological Malignancies”
by Shailendra Kumar Dhar Dwivedi, Geeta Rao, Anindya Dey, Priyabrata Mukherjee, Jonathan D. Wren and Resham Bhattacharya
Cancers 2021, 13(5), 1085; https://doi.org/10.3390/cancers13051085
Available online: https://www.mdpi.com/2072-6694/13/5/1085

“The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer”
by Rina Masadah, Syahrul Rauf, Muhammad Yogi Pratama, Claudio Tiribelli and Devis Pascut
Cancers 2021, 13(5), 1168; https://doi.org/10.3390/cancers13051168
Available online: https://www.mdpi.com/2072-6694/13/5/1168

“Carbonic Anhydrase IX Promotes Human Cervical Cancer Cell Motility by Regulating PFKFB4 Expression”
by Min-Chieh Hsin, Yi-Hsien Hsieh, Yi-Hsuan Hsiao, Pei-Ni Chen, Po-Hui Wang and Shun-Fa Yang
Cancers 2021, 13(5), 1174; https://doi.org/10.3390/cancers13051174
Available online: https://www.mdpi.com/2072-6694/13/5/1174

“Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data”
by Simona Duranti, Antonella Pietragalla, Gennaro Daniele, Camilla Nero, Francesca Ciccarone, Giovanni Scambia and Domenica Lorusso
Cancers 2021, 13(9), 2089; https://doi.org/10.3390/cancers13092089
Available online: https://www.mdpi.com/2072-6694/13/9/2089

“Molecular and Cellular Mechanisms of Metformin in Cervical Cancer”
by Ya-Hui Chen, Po-Hui Wang, Pei-Ni Chen, Shun-Fa Yang and Yi-Hsuan Hsiao
Cancers 2021, 13(11), 2545; https://doi.org/10.3390/cancers13112545
Available online: https://www.mdpi.com/2072-6694/13/11/2545

“Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment”
by Boštjan Pirš, Erik Škof, Vladimir Smrkolj and Špela Smrkolj
Cancers 2022, 14(3), 631; https://doi.org/10.3390/cancers14030631
Available online: https://www.mdpi.com/2072-6694/14/3/631

“Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?”
by Saikat Mitra, Mashia Subha Lami, Avoy Ghosh, Rajib Das, Trina Ekawati Tallei, Fatimawali, Fahadul Islam, Kuldeep Dhama, M. Yasmin Begum, Afaf Aldahish et al.
Cancers 2022, 14(3), 759; https://doi.org/10.3390/cancers14030759
Available online: https://www.mdpi.com/2072-6694/14/3/759

“Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models”
by Ha-Yeon Shin, Eun-ju Lee, Wookyeom Yang, Hyo Sun Kim, Dawn Chung, Hanbyoul Cho and Jae-Hoon Kim
Cancers 2022, 14(3), 829; https://doi.org/10.3390/cancers14030829
Available online: https://www.mdpi.com/2072-6694/14/3/829

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office